ArticleInternational journal of clinical and experimental pathology2018
Focal adhesion kinase (FAK) is associated with poor prognosis in urinary bladder carcinoma.
Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 17 citations in OpenAlex.
- Activation of the FAK-MAPK/ERK1 pathway promotes intestinal epithelial cell sheet migration during fistula tract repair.Scientific reports · 2026Article
- TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.Oncogene · 2025Article
- The role of focal adhesion kinase in bladder cancer: translation fromRadiology and oncology · 2025Article
- Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins.Cells · 2025Article
- Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model.Discover oncology · 2024Article
- Clinical Importance of Focal Adhesion Kinase (FAK)-Src and Paxillin Expression in Renal Cell Carcinoma.Cureus · 2024Article
- Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence.Frontiers in oncology · 2024Review
- Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway.Scientific reports · 2023Article
- New Insights on the Nuclear Functions and Targeting of FAK in Cancer.International journal of molecular sciences · 2022Review
- Article
- Article
- FAK Signaling in Rhabdomyosarcoma.International journal of molecular sciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveOverexpression of the enhancer of focal adhesion kinase (FAK) protein, an intracellular tyrosine kinase protein, has been reported to be associated with biological malignancy of gastric cancer and several other tumors. The purpose of this study was to examine the expression of FAK and analyze its correlation with the clinicopathological features of human urinary bladder carcinoma.
methods315 archived cases of urinary bladder carcinoma were reviewed and TMAs were developed as per established procedures. Immunohistochemical staining for FAK was performed to assess the correlation between the expression profiles and the clinicopathological parameters and clinical outcome.
resultsProtein level of FAK was up-regulated in urinary bladder carcinoma compared with adjacent non-tumor tissues. Overexpression of FAK was significantly associated with high histologic grade, angiolymphatic invasion, lymph node metastasis, myometrial invasion and cervical involvement (P < 0.05). Further multivariate analysis suggested that expression of FAK was independent prognostic indicator for urinary bladder carcinoma. These alterations in expression were also associated with greater risk of disease progression and decreased chance of carcinoma-specific survival. Kaplan-Meier analysis demonstrates that overexpression of FAK was significantly associated with decreased overall survival.
conclusionOverexpression of FAK corelates with well established pathologic risk factors and may predict more aggressive biologic behavior in urinary bladder carcinoma. The expression patterns of FAK correlated well with the pathologic stage, disease progression, and carcinoma-specific survival. This finding may aid in identifying more biologically aggressive carcinomas and thus patients who could benefit from more intensive adjuvant therapy.
Indexed as
Identifiers
31938172PMC6958047W3027107887What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.